Skip to main content
Clinical Trials/JPRN-UMIN000037308
JPRN-UMIN000037308
Completed
未知

Observational, prospective study to examine association values of Interferon-Gamma Release Assay (IGRA) before and after treatment and clinical response or adverse events in patients with lung cancer who received cytotoxic cancer chemotherapy containing platinum with or without Immune Checkpoint Inhibitor (ICI) - Observational, prospective study to examine association values of Interferon-Gamma Release Assay (IGRA) before and after treatment and clinical response or adverse events in patients with lung cancer who received cytotoxic cancer chemotherapy containing platinum with or without Immune Checkpoint Inhibitor (ICI)

Osaka Prefectural Hospital Organization Osaka Habikino Medical Center0 sites46 target enrollmentJuly 10, 2019
Conditionsung Cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
ung Cancer
Sponsor
Osaka Prefectural Hospital Organization Osaka Habikino Medical Center
Enrollment
46
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2019
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Osaka Prefectural Hospital Organization Osaka Habikino Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Patient with synchronou or metachronous lung cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials